Literature DB >> 3643816

Regulation of mRNA accumulation by a human immunodeficiency virus trans-activator protein.

M A Muesing, D H Smith, D J Capon.   

Abstract

HIV LTR-directed expression is markedly stimulated in trans by coexpression of a region of the HIV genome encoding a portion of the tat reading frame. Transient expression assay analysis reveals that trans-activation of LTR-directed expression results primarily from an increase in mRNA accumulation. Deletion analysis of the LTR indicates that upstream promoter and enhancer elements are dispensible for trans-activation, while sequences 3' of the RNA start site displaying strict orientation and position dependence are required. These sequences, contained in the 5' leader of all HIV transcripts, form a stable stem-loop structure with twofold symmetry in the cognate mRNA. Analysis of mutations in the trans-acting region demonstrates that the trans-activator is the protein product of the tat gene, identified biochemically in HIV-infected and transfected cells as an Mr 15,000 polypeptide. We discuss possible mechanisms whereby the interaction of p15tat with the dyad element promotes the accumulation of LTR-directed mRNA.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3643816     DOI: 10.1016/0092-8674(87)90247-9

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  338 in total

1.  NMR characterization of a kissing complex formed between the TAR RNA element of HIV-1 and a DNA aptamer.

Authors:  D Collin; C van Heijenoort; C Boiziau; J J Toulmé; E Guittet
Journal:  Nucleic Acids Res       Date:  2000-09-01       Impact factor: 16.971

2.  The effect of viral regulatory protein expression on gene delivery by human immunodeficiency virus type 1 vectors produced in stable packaging cell lines.

Authors:  N Srinivasakumar; N Chazal; C Helga-Maria; S Prasad; M L Hammarskjöld; D Rekosh
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

3.  Identification of sequences downstream of the primer binding site that are important for efficient replication of human immunodeficiency virus type 1.

Authors:  X Li; C Liang; Y Quan; R Chandok; M Laughrea; M A Parniak; L Kleiman; M A Wainberg
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

4.  Analysis of regulatory elements of the equine infectious anemia virus and caprine arthritis-encephalitis virus long terminal repeats.

Authors:  L Sherman; A Yaniv; H Lichtman-Pleban; S R Tronick; A Gazit
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

5.  A region of basic amino-acid cluster in HIV-1 Tat protein is essential for trans-acting activity and nucleolar localization.

Authors:  S Endo; S Kubota; H Siomi; A Adachi; S Oroszlan; M Maki; M Hatanaka
Journal:  Virus Genes       Date:  1989-11       Impact factor: 2.332

6.  Persistent infection of rabbits with bovine leukemia virus associated with development of immune dysfunction.

Authors:  C R Wyatt; D Wingett; J S White; C D Buck; D Knowles; R Reeves; N S Magnuson
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

7.  Functional analysis of the Tat trans activator of human immunodeficiency virus type 2.

Authors:  R Fenrick; M H Malim; J Hauber; S Y Le; J Maizel; B R Cullen
Journal:  J Virol       Date:  1989-12       Impact factor: 5.103

8.  Herpes simplex virus trans-regulatory protein ICP27 stabilizes and binds to 3' ends of labile mRNA.

Authors:  C R Brown; M S Nakamura; J D Mosca; G S Hayward; S E Straus; L P Perera
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

9.  Identification of cellular proteins that bind to the human immunodeficiency virus type 1 trans-activation-responsive TAR element RNA.

Authors:  A Gatignol; A Kumar; A Rabson; K T Jeang
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

10.  Infection with the intracellular protozoan parasite Theileria parva induces constitutively high levels of NF-kappa B in bovine T lymphocytes.

Authors:  V Ivanov; B Stein; I Baumann; D A Dobbelaere; P Herrlich; R O Williams
Journal:  Mol Cell Biol       Date:  1989-11       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.